Trial intelligence / Profile preview

Dexmedetomidine effect on glucose in bariatric surgery

NCT03809182Phase 4Completed

Sponsor
Pontificia Universidad Católica de Chile
Start
Sep 2012
Primary completion
Jul 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of dexmedetomidine in obesity, impaired glucose tolerance (IGT), sponsored by Pontificia Universidad Católica de Chile. Started Sep 2012; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

obesityimpaired glucose tolerance (IGT)

Beyond the preview

Go deeper on NCT03809182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03809182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call